Form D — Silexion Therapeutics Corp
0001178913-25-002710 · filed Aug 11, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $3,597,662
- Reported amount sold
- $3,597,662
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Silexion Therapeutics Corp
- CIK
- 2022416
- Entity
- Corporation
- Jurisdiction
- CAYMAN ISLANDS
- Year incorporated
- 2024
- Address
- 12 ABBA HILLEL ROAD
RAMAT GAN, Israel 5250606 - Phone
- +972-3-756-4999
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ilan Hadar · Executive OfficerRamat Gan, Israel Find on LinkedIn ↗
-
Mirit Horenshtein-Hadar · Executive OfficerRamat Gan, Israel Find on LinkedIn ↗
-
Ruth Alon · DirectorRamat Gan, Israel Find on LinkedIn ↗
-
Ilan Levin · DirectorRamat Gan, Israel Find on LinkedIn ↗
-
Avner Lushi · DirectorRamat Gan, Israel Find on LinkedIn ↗
-
Shlomo Noy · DirectorRamat Gan, Israel Find on LinkedIn ↗
-
Amnon Peled · DirectorRamat Gan, Israel Find on LinkedIn ↗
-
Dror Abramov · DirectorRamat Gan, Israel Find on LinkedIn ↗
-
Mitchell Shirvan · Executive OfficerRamat Gan, Israel Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗